✦ LIBER ✦

Targeted therapies: Doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma

✍ Scribed by Hutchinson, Lisa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Skin toxicities and survival in advanced

✍ Taiga Otsuka; Yuichiro Eguchi; Seiji Kawazoe; Kimihiko Yanagita; Keisuke Ario; K 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Tamoxifen improves survival in patients

✍ Cerezo, F.J.Martínez; Tomás, A.; Enríquez, J.; Donoso, L.; Balanzó, J.; Guarner, 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Survival of patients with advanced hepat

✍ Hwi Young Kim; Joong-Won Park; Byung-Ho Nam; Hyun Keun Kim; Joon-Il Choi; Tae Hy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

P982 MULTIDISCIPLINARY TREATMENTS IMPROV

✍ Hattori, N.; Tsuchiya, K.; Nakakuki, N.; Takada, H.; Matsuda, S.; Kaneko, S.; Mu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PR-104 plus sorafenib in patients with a

✍ Ghassan K. Abou-Alfa; Stephan L. Chan; Chia-Chi Lin; E. Gabriela Chiorean; Randa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 180 KB

Prognostic factors in patients with adva

✍ M. Pinter; W. Sieghart; F. Hucke; I. Graziadei; W. Vogel; A. Maieron; R. Königsb 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB